
Vipul Organics (VIPULORG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
376.0M
Gross Profit
130.6M
34.72%
Operating Income
22.4M
5.96%
Net Income
12.6M
3.36%
EPS (Diluted)
₹0.86
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
916.1M
Shareholders Equity
637.0M
Debt to Equity
1.44
Cash Flow Metrics
Revenue & Profitability Trend
Vipul Organics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.6B | 1.5B | 1.3B | 1.3B | 1.2B |
Cost of Goods Sold | 1.1B | 1.1B | 947.2M | 943.1M | 815.9M |
Gross Profit | 478.3M | 410.2M | 377.9M | 370.5M | 348.2M |
Gross Margin % | 29.7% | 27.6% | 28.5% | 28.2% | 29.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 91.2M | 74.9M | 58.9M | 57.2M | 61.4M |
Other Operating Expenses | 79.0M | 78.4M | 70.2M | 63.9M | 40.9M |
Total Operating Expenses | 170.2M | 153.2M | 129.0M | 121.1M | 102.3M |
Operating Income | 87.1M | 60.5M | 59.7M | 95.4M | 107.0M |
Operating Margin % | 5.4% | 4.1% | 4.5% | 7.3% | 9.2% |
Non-Operating Items | |||||
Interest Income | 1.7M | 1.1M | 819.0K | 1.1M | 759.0K |
Interest Expense | 25.8M | 23.5M | 24.6M | 16.3M | 12.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 63.4M | 46.2M | 27.3M | 97.4M | 95.6M |
Income Tax | 19.1M | 12.8M | 8.6M | 27.7M | 27.1M |
Effective Tax Rate % | 30.1% | 27.8% | 31.4% | 28.5% | 28.3% |
Net Income | 44.3M | 33.4M | 18.7M | 69.7M | 68.5M |
Net Margin % | 2.7% | 2.2% | 1.4% | 5.3% | 5.9% |
Key Metrics | |||||
EBITDA | 146.8M | 117.9M | 116.3M | 161.7M | 160.6M |
EPS (Basic) | ₹2.70 | ₹2.60 | ₹1.47 | ₹5.76 | ₹4.82 |
EPS (Diluted) | ₹2.70 | ₹2.60 | ₹1.47 | ₹5.76 | ₹4.82 |
Basic Shares Outstanding | 16379679 | 12875163 | 12811875 | 12116897 | 14217968 |
Diluted Shares Outstanding | 16379679 | 12875163 | 12811875 | 12116897 | 14217968 |
Income Statement Trend
Vipul Organics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 8.8M | 7.6M | 43.8M | 18.2M | 50.0M |
Short-term Investments | 22.0M | 20.9M | 19.7M | 17.9M | 16.8M |
Accounts Receivable | 508.1M | 444.6M | 340.0M | 426.1M | 353.7M |
Inventory | 364.0M | 334.3M | 353.9M | 308.0M | 180.8M |
Other Current Assets | 1.0K | 3.0K | -1.0K | -3.0K | -1.0K |
Total Current Assets | 1.0B | 932.9M | 837.8M | 861.0M | 733.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 380.8M | 321.9M | 351.5M | 360.5M | 284.9M |
Goodwill | 711.0K | 488.0K | 659.0K | 889.0K | 1.2M |
Intangible Assets | 711.0K | 488.0K | 659.0K | 889.0K | 1.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -1.0K | 5.0K | -1.0K | 1.0K | -1.0K |
Total Non-Current Assets | 546.0M | 427.7M | 402.7M | 406.5M | 336.4M |
Total Assets | 1.6B | 1.4B | 1.2B | 1.3B | 1.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 364.6M | 401.9M | 333.5M | 391.1M | 332.4M |
Short-term Debt | 380.6M | 268.8M | 231.4M | 229.2M | 178.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 6.2M | 8.3K | 5.0K | 1.0K | 8.5M |
Total Current Liabilities | 819.2M | 736.8M | 616.6M | 668.9M | 559.6M |
Non-Current Liabilities | |||||
Long-term Debt | 96.7M | 42.6M | 89.3M | 73.3M | 102.0M |
Deferred Tax Liabilities | - | 0 | -1.7M | 3.5M | 4.7M |
Other Non-Current Liabilities | - | -1.0K | 5.9M | -1.0K | 1.0K |
Total Non-Current Liabilities | 96.9M | 42.8M | 95.3M | 76.9M | 106.8M |
Total Liabilities | 916.1M | 779.6M | 712.0M | 745.8M | 666.4M |
Equity | |||||
Common Stock | 133.1M | 130.1M | 128.1M | 102.5M | 95.5M |
Retained Earnings | 299.6M | 268.4M | 246.4M | 238.8M | 177.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 637.0M | 581.0M | 528.6M | 521.7M | 403.1M |
Key Metrics | |||||
Total Debt | 477.3M | 311.4M | 320.6M | 302.4M | 280.8M |
Working Capital | 187.8M | 196.1M | 221.2M | 192.1M | 173.5M |
Balance Sheet Composition
Vipul Organics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 63.4M | 46.2M | 27.3M | 97.4M | 95.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -82.4M | -123.2M | 62.6M | -163.6M | -136.6M |
Operating Cash Flow | 5.7M | -54.4M | 114.6M | -52.2M | -26.8M |
Investing Activities | |||||
Capital Expenditures | -158.9M | -69.6M | -31.1M | -122.0M | -14.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | 4.8M | - | 0 | 10.4M | 0 |
Investing Cash Flow | -154.1M | -69.6M | -31.1M | -111.6M | -14.9M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -13.2M | -11.5M | -11.8M | -8.8M | -7.9M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 120.0M | 54.6M | -15.1M | 99.3M | 38.0M |
Free Cash Flow | -152.6M | -21.2M | 70.2M | -110.4M | -35.6M |
Net Change in Cash | -28.3M | -69.4M | 68.5M | -64.5M | -3.7M |
Cash Flow Trend
Vipul Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
70.46
Price to Book
5.20
Price to Sales
2.20
PEG Ratio
3.08
Profitability Ratios
Profit Margin
2.80%
Operating Margin
5.94%
Return on Equity
6.95%
Return on Assets
2.85%
Financial Health
Current Ratio
1.23
Debt to Equity
72.94
Beta
-0.02
Per Share Data
EPS (TTM)
₹2.85
Book Value per Share
₹38.63
Revenue per Share
₹101.60
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
vipulorg | 3.6B | 70.46 | 5.20 | 6.95% | 2.80% | 72.94 |
Asian Paints | 2.3T | 62.12 | 11.55 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.5T | 69.64 | 15.54 | 20.85% | 16.16% | 4.56 |
Tanfac Industries | 47.5B | 47.66 | 14.73 | 32.50% | 15.83% | 13.28 |
Balaji Amines | 46.1B | 29.87 | 2.47 | 7.80% | 11.11% | 0.55 |
Camlin Fine Sciences | 40.4B | 51.69 | 3.95 | -15.89% | -6.73% | 77.88 |
Financial data is updated regularly. All figures are in the company's reporting currency.